ArticleCancer cell international2024

Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer.

Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.